BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10621811)

  • 21. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.
    Glare P; Pereira G; Kristjanson LJ; Stockler M; Tattersall M
    Support Care Cancer; 2004 Jun; 12(6):432-40. PubMed ID: 15108099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of nausea and vomiting in palliative care.
    Neoh K; Adkinson L; Montgomery V; Hurlow A
    Br J Hosp Med (Lond); 2014 Jul; 75(7):391-2, 394-6. PubMed ID: 25040518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABC of palliative care. Nausea, vomiting, and intestinal obstruction.
    Baines MJ
    BMJ; 1997 Nov; 315(7116):1148-50. PubMed ID: 9374893
    [No Abstract]   [Full Text] [Related]  

  • 24. Practical selection of antiemetics.
    Flake ZA; Scalley RD; Bailey AG
    Am Fam Physician; 2004 Mar; 69(5):1169-74. PubMed ID: 15023018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE).
    McCabe HL; Maraveyas A
    Anticancer Res; 2003; 23(6D):5209-12. PubMed ID: 14981991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nausea and vomiting in advanced cancer.
    Ang SK; Shoemaker LK; Davis MP
    Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
    Srivastava M; Brito-Dellan N; Davis MP; Leach M; Lagman R
    J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of haloperidol in palliative medicine: an update.
    Prommer E
    Am J Hosp Palliat Care; 2012 Jun; 29(4):295-301. PubMed ID: 21998445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review.
    Critchley P; Plach N; Grantham M; Marshall D; Taniguchi A; Latimer E; Jadad AR
    J Pain Symptom Manage; 2001 Aug; 22(2):631-4. PubMed ID: 11503632
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of methotrimeprazine and meperidine as analgesic agents.
    Stirman JA
    Anesth Analg; 1967; 46(2):176-80. PubMed ID: 5335723
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiemetic therapy in pediatric emergency departments.
    Freedman SB; Fuchs S
    Pediatr Emerg Care; 2004 Sep; 20(9):625-33; quiz 633-5. PubMed ID: 15599268
    [No Abstract]   [Full Text] [Related]  

  • 33. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
    Kaneishi K; Kawabata M; Morita T
    J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Appetite loss, nausea, vomiting].
    Sakamaki S
    Nihon Rinsho; 2007 Jan; 65(1):69-75. PubMed ID: 17233418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of nausea and vomiting in the cancer patient.
    Frytak S; Moertel CG
    JAMA; 1981 Jan 23-30; 245(4):393-6. PubMed ID: 7452866
    [No Abstract]   [Full Text] [Related]  

  • 36. Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
    Hernandez SL; Sheyner I; Stover KT; Stewart JT
    Am J Hosp Palliat Care; 2015 Feb; 32(1):5-7. PubMed ID: 24052427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of nausea and vomiting.
    Sykes N
    Practitioner; 1990 Mar; 234(1485):286-90. PubMed ID: 2284268
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanistic approach to the management of cancer-related nausea and vomiting in a palliative care resource-limited setting.
    Fernando GC; Kondasinghe JS
    Int J Palliat Nurs; 2021 Sep; 27(7):362-366. PubMed ID: 34569286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence.
    Chasen MR; Rapoport BL
    Future Oncol; 2016 Mar; 12(6):763-78. PubMed ID: 26842387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine antagonists for nausea and vomiting: special considerations.
    Welliver M
    Gastroenterol Nurs; 2014; 37(5):361-4. PubMed ID: 25271829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.